MedTrace Logo

Serotonin and Motor Plasticity

NCT03162185 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2017-05-22

No results posted yet for this study

Summary

With this study, the investigators aim to test whether acute administration of selective serotonin reuptake inhibitors (SSRI) improves motor performance in a sequential motor learning task in comparison to placebo in healthy humans.

Conditions

  • Healthy Controls

Interventions

DRUG

Escitalopram

Experimental group participants (n = 30) will receive 20 mg of Escitalopram for 7 days.

DRUG

Placebo

Control group participants (n = 30) will receive a placebo for 7 days.

Sponsors & Collaborators

  • University of Leipzig

    collaborator OTHER

  • Max Planck Institute for Human Cognitive and Brain Sciences

    lead OTHER

Principal Investigators

  • Arno Villringer · Max Planck Institute for Human Cognitive and Brain Sciences

  • Julia Sacher · Max Planck Institute for Human Cognitive and Brain Sciences

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-04-01
Primary Completion
2017-11-30
Completion
2017-11-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03162185 on ClinicalTrials.gov